Exact Mass: 293.1838

Exact Mass Matches: 293.1838

Found 399 metabolites which its exact mass value is equals to given mass value 293.1838, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Nordihydrocapsaicin

N-[(4-Hydroxy-3-methoxyphenyl)methyl]-7-methyl-octanamide;7-Methyl-N-vanillyl-octanamide; Norhydrocapsaicin

C17H27NO3 (293.1991)


Nordihydrocapsaicin is a member of methoxybenzenes and a member of phenols. Nordihydrocapsaicin is a natural product found in Capsicum pubescens and Capsicum annuum with data available. See also: Capsicum (part of); Paprika (part of); Habanero (part of) ... View More ... Isolated from the pungent principle of red pepper (Capsicum annuum). Nordihydrocapsaicin is found in many foods, some of which are herbs and spices, pepper (c. annuum), italian sweet red pepper, and green bell pepper. Nordihydrocapsaicin is found in herbs and spices. Nordihydrocapsaicin is isolated from the pungent principle of red pepper (Capsicum annuum Nordihydrocapsaicin is a capsaicinoid analog and congener of capsaicin in chili peppers[1]. Nordihydrocapsaicin is a capsaicinoid analog and congener of capsaicin in chili peppers[1].

   
   

AMITRAZ

Pesticide4_Amitraz_C19H23N3_N-(2,4-Dimethylphenyl)-N-{(E)-[(2,4-dimethylphenyl)imino]methyl}-N-methylimidoformamide

C19H23N3 (293.1892)


D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D010575 - Pesticides > D010574 - Pesticide Synergists D010575 - Pesticides > D007302 - Insect Repellents D010575 - Pesticides > D007306 - Insecticides D020011 - Protective Agents D016573 - Agrochemicals CONFIDENCE standard compound; INTERNAL_ID 3023 CONFIDENCE standard compound; EAWAG_UCHEM_ID 107 Amitraz is a non-systemic acaricide and insecticide with alpha-adrenergic agonist activity that interacts with octopamine receptors in the central nervous system and inhibits monoamine oxidase and prostaglandin synthesis.

   

pramoxine

gamma-Morpholinopropyl 4-n-butoxyphenyl ether

C17H27NO3 (293.1991)


D - Dermatologicals > D04 - Antipruritics, incl. antihistamines, anesthetics, etc. > D04A - Antipruritics, incl. antihistamines, anesthetics, etc. > D04AB - Anesthetics for topical use C - Cardiovascular system > C05 - Vasoprotectives > C05A - Agents for treatment of hemorrhoids and anal fissures for topical use > C05AD - Local anesthetics D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent CONFIDENCE standard compound; EAWAG_UCHEM_ID 3273

   

Ondansetron

9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-2,3,4,9-tetrahydro-1H-carbazol-4-one

C18H19N3O (293.1528)


Ondansetron is a well tolerated drug with few side effects. Headache, constipation, and dizziness are the most commonly reported side effects associated with its use. There have been no significant drug interactions reported with this drugs use. It is broken down by the hepatic cytochrome P450 system and it has little effect on the metabolism of other drugs broken down by this system; Ondansetron is a serotonin 5-HT3 receptor antagonist used mainly to treat nausea and vomiting following chemotherapy. Its effects are thought to be on both peripheral and central nerves. One part is to reduce the activity of the vagus nerve, which is a nerve that activates the vomiting center in the medulla oblongata, the other is a blockage of serotonin receptors in the chemoreceptor trigger zone. It does not have much effect on vomiting due to motion sickness. This drug does not have any effect on dopamine receptors or muscarinic receptors; A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties; Ondansetron (INN) is a serotonin 5-HT3 receptor antagonist used mainly to treat nausea and vomiting following chemotherapy. Its effects are thought to be on both peripheral and central nerves. One part is to reduce the activity of the vagus nerve, which is a nerve that activates the vomiting center in the medulla oblongata, the other is a blockage of serotonin receptors in the chemoreceptor trigger zone. It does not have much effect on vomiting due to motion sickness. This drug does not have any effect on dopamine receptors or muscarinic receptors. [HMDB] Ondansetron is a well tolerated drug with few side effects. Headache, constipation, and dizziness are the most commonly reported side effects associated with its use. There have been no significant drug interactions reported with this drugs use. It is broken down by the hepatic cytochrome P450 system and it has little effect on the metabolism of other drugs broken down by this system; Ondansetron is a serotonin 5-HT3 receptor antagonist used mainly to treat nausea and vomiting following chemotherapy. Its effects are thought to be on both peripheral and central nerves. One part is to reduce the activity of the vagus nerve, which is a nerve that activates the vomiting center in the medulla oblongata, the other is a blockage of serotonin receptors in the chemoreceptor trigger zone. It does not have much effect on vomiting due to motion sickness. This drug does not have any effect on dopamine receptors or muscarinic receptors; A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties; Ondansetron (INN) is a serotonin 5-HT3 receptor antagonist used mainly to treat nausea and vomiting following chemotherapy. Its effects are thought to be on both peripheral and central nerves. One part is to reduce the activity of the vagus nerve, which is a nerve that activates the vomiting center in the medulla oblongata, the other is a blockage of serotonin receptors in the chemoreceptor trigger zone. It does not have much effect on vomiting due to motion sickness. This drug does not have any effect on dopamine receptors or muscarinic receptors. A - Alimentary tract and metabolism > A04 - Antiemetics and antinauseants > A04A - Antiemetics and antinauseants > A04AA - Serotonin (5ht3) antagonists C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist > C94726 - 5-HT3 Receptor Antagonist D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D003879 - Dermatologic Agents > D000982 - Antipruritics CONFIDENCE standard compound; INTERNAL_ID 2746 CONFIDENCE standard compound; INTERNAL_ID 8525 D002491 - Central Nervous System Agents Ondansetron (GR 38032; SN 307) is a highly selective 5-HT3 receptor antagonist, with IC50 value of 103 pM. Ondansetron exerts antiemetic effects by antagonizing 5-HT receptor located on local neurons in the peripheral and central nervous system. Ondansetron suppresses nausea and vomiting caused by chemotherapy and radiation therapy. Ondansetron has orally bioactivity[1][2][3][4][5][6][7][8].

   

Anastrozole

alpha,alpha,Alpha,alpha-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile

C17H19N5 (293.164)


Anastrozole is a drug indicated in the treatment of breast cancer in post-menopausal women. It is used both in adjuvant therapy (i.e. following surgery) and in metastatic breast cancer. It decreases the amount of estrogens that the body makes. Anastrozole belongs in the class of drugs known as aromatase inhibitors. It inhibits the enzyme aromatase, which is responsible for converting androgens (produced by women in the adrenal glands) to estrogens. CONFIDENCE standard compound; INTERNAL_ID 166; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7616; ORIGINAL_PRECURSOR_SCAN_NO 7613 CONFIDENCE standard compound; INTERNAL_ID 166; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7651; ORIGINAL_PRECURSOR_SCAN_NO 7649 CONFIDENCE standard compound; INTERNAL_ID 166; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7606; ORIGINAL_PRECURSOR_SCAN_NO 7604 CONFIDENCE standard compound; INTERNAL_ID 166; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7609; ORIGINAL_PRECURSOR_SCAN_NO 7607 CONFIDENCE standard compound; INTERNAL_ID 166; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7592; ORIGINAL_PRECURSOR_SCAN_NO 7590 CONFIDENCE standard compound; INTERNAL_ID 166; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7638; ORIGINAL_PRECURSOR_SCAN_NO 7636 L - Antineoplastic and immunomodulating agents > L02 - Endocrine therapy > L02B - Hormone antagonists and related agents > L02BG - Aromatase inhibitors D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D065088 - Steroid Synthesis Inhibitors D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D004965 - Estrogen Antagonists C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D004791 - Enzyme Inhibitors > D065088 - Steroid Synthesis Inhibitors > D047072 - Aromatase Inhibitors C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1740 - Aromatase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist CONFIDENCE standard compound; INTERNAL_ID 2750 CONFIDENCE standard compound; INTERNAL_ID 8532 D000970 - Antineoplastic Agents

   

Dihydrobunolol

(+/-)-5-[(tert-Butylamino)-2-hydroxypropoxy]-1,2,3,4-tetrahydro-1-naphthol

C17H27NO3 (293.1991)


   
   

Nonivamide

NonivamideAnemarsaponin EAnhydrosecoisolariciresinolConessineQuercetin-3-O-β-D-glucose-7-O-β-D-gentiobiosidenCornuside4-AllylcatecholZingibereneConiferinSchisantherin EVomifoliol5-MethylfurfuralWithanoneMauritianinGardenin B

C17H27NO3 (293.1991)


Nonivamide, also known as pseudocapsaicin or hansaplast, belongs to the class of organic compounds known as methoxyphenols. Methoxyphenols are compounds containing a methoxy group attached to the benzene ring of a phenol moiety. Nonivamide is odorless and a bland tasting compound. Nonivamide is found, on average, in the highest concentration within a few different foods, such as yellow bell peppers, red bell peppers, and pepper (C. frutescens) and in a lower concentration in pepper (C. annuum), orange bell peppers, and green bell peppers. Nonivamide has also been detected, but not quantified, in herbs and spices. This could make nonivamide a potential biomarker for the consumption of these foods. Limited information is available on pharmacokinetics and metabolism of nonivamide. Agonism of the VR1 (TRPV1) (vanilloid) receptor by Nonivamide was demonstrated to induce the release of Ca2+ from the endoplasmic reticulum (ER) of human lung cells, producing ER stress and cell death . The cardiovascular effects are partly explained by substance P release. Administered intraperitoneally, the LD50 in rats was measured to be about 90 mg/kg. Nonivamide has been shown to stimulate afferent neurons with about half the potency of Capsaicin (PMID:6202305). Nonivamide is a capsaicinoid that is the carboxamide resulting from the formal condensation of the amino group of 4-hydroxy-3-methoxybenzylamine with the carboxy group of nonanoic acid. It is the active ingredient in many pepper sprays. It has a role as a lachrymator. It is a capsaicinoid and a member of phenols. Nonivamide is found in herbs and spices. It is an alkaloid from the Capsicum species. The structures of [DB06774] and nonivamide differ only slightly with respect to the fatty acid moiety of the side chain (8-methyl nonenoic acid versus nonanoic acid). Nonivamide is a flavoring ingredient. Nonivamide is an organic compound and a capsaicinoid. It is an amide of pelargonic acid and vanillylamine. It is naturally found in chili peppers but manufactured to produce a synthetic form for various pharmacologic preparations. This drug has been studied in combination with Nicarboxil in the treatment of lower back pain. Nonivamide has also been studied for its anti-inflammatory properties, as well as in fat loss therapies and has demonstrated promising results,,,. Nonivamide is a natural product found in Capsicum annuum with data available. See also: Paprika (part of); Methyl salicylate; nonivamide (component of) ... View More ... A capsaicinoid that is the carboxamide resulting from the formal condensation of the amino group of 4-hydroxy-3-methoxybenzylamine with the carboxy group of nonanoic acid. It is the active ingredient in many pepper sprays. Alkaloid from Capsicum subspecies Flavouring ingredient Nonivamide is a

   

Dehydronuciferine

15,16-dimethoxy-10-methyl-10-azatetracyclo[7.7.1.0^{2,7}.0^{13,17}]heptadeca-1(16),2,4,6,8,13(17),14-heptaene

C19H19NO2 (293.1416)


Dehydronuciferine is found in coffee and coffee products. Dehydronuciferine is an alkaloid from the leaves of Nelumbo nucifera (East Indian lotus). Dehydronuciferine is an isoquinoline alkaloid. Dehydronuciferine is a natural product found in Nelumbo nucifera with data available. Dehydronuciferine is isolated from the leaves of Nelumbo nucifera Gaertn, a acetylcholinesterase (AChE) inhibitor with an IC50 of 25 μg/mL[1]. Dehydronuciferine is isolated from the leaves of Nelumbo nucifera Gaertn, a acetylcholinesterase (AChE) inhibitor with an IC50 of 25 μg/mL[1].

   

N-Fructosyl isoleucine

(2S)-3-methyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)oxolan-2-yl]methyl}amino)pentanoic acid

C12H23NO7 (293.1474)


Fructose aminoacids are naturally occurring compounds derived from D-fructose and L-aminoacids. They are amadori products resulting from sugar-aminoacid interactions in food products, especially cooked foods [CCD] N-(1-Deoxy-1-fructosyl)isoleucine is classified as a Natural Food Constituent (code WA) in the DFC.

   

Phenylalanyllysine

(2S)-6-Amino-2-{[(2S)-2-amino-3-phenylpropanoyl]amino}hexanoic acid

C15H23N3O3 (293.1739)


Phenylalanyllysine is a dipeptide composed of phenylalanine and lysine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Koenimbine

13-methoxy-5,5,8-trimethyl-6-oxa-17-azatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-1,3,7,9,11(16),12,14-heptaene

C19H19NO2 (293.1416)


Koenimbine is found in herbs and spices. Koenimbine is an alkaloid from leaves and fruits of Murraya koenigii (curryleaf tree

   

Lysylphenylalanine

(2S)-2-[(2S)-2,6-diaminohexanamido]-3-phenylpropanoic acid

C15H23N3O3 (293.1739)


Lysylphenylalanine is a dipeptide composed of lysine and phenylalanine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Phenylalanylglutamine

(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-carbamoylbutanoic acid

C14H19N3O4 (293.1375)


Phenylalanylglutamine is a dipeptide composed of phenylalanine and glutamine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

E-10-Hydroxyamitriptyline

(2E)-2-[3-(dimethylamino)propylidene]tricyclo[9.4.0.0³,⁸]pentadeca-1(15),3,5,7,11,13-hexaen-9-ol

C20H23NO (293.178)


E-10-Hydroxyamitriptyline is only found in individuals that have used or taken Amitriptyline. E-10-Hydroxyamitriptyline is a metabolite of Amitriptyline. E-10-hydroxyamitriptyline belongs to the family of Dibenzocycloheptenes. These are compounds containing a dibenzocycloheptene moiety, which consists of two benzene connected by a cycloheptene ring.

   

Glutaminylphenylalanine

(2S)-2-{[(2S)-2-amino-1-hydroxy-4-(C-hydroxycarbonimidoyl)butylidene]amino}-3-phenylpropanoic acid

C14H19N3O4 (293.1375)


Glutaminylphenylalanine is a dipeptide composed of glutamine and phenylalanine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Phenylalanyl-Gamma-glutamate

2-Amino-4-[(2-amino-3-phenylpropanoyl)-C-hydroxycarbonimidoyl]butanoate

C14H19N3O4 (293.1375)


Phenylalanyl-Gamma-glutamate is a dipeptide composed of phenylalanine and gamma-glutamate. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

N-(1-Deoxy-1-fructosyl)leucine

(2S)-4-methyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)oxolan-2-yl]methyl}amino)pentanoic acid

C12H23NO7 (293.1474)


Fructose aminoacids are naturally occurring compounds derived from D-fructose and L-aminoacids. They are amadori products resulting from sugar-aminoacid interactions in food products, especially cooked foods [CCD] N-(1-Deoxy-1-fructosyl)leucine is classified as a Natural Food Constituent (code WA) in the DFC.

   

N-Acetyl-3-hydroxyprocainamide

N-[2-(diethylamino)ethyl]-3-hydroxy-4-[(1-hydroxyethylidene)amino]benzene-1-carboximidic acid

C15H23N3O3 (293.1739)


N-Acetyl-3-hydroxyprocainamide is a metabolite of procainamide. Procainamide is a pharmaceutical antiarrhythmic agent used for the medical treatment of cardiac arrhythmias, classified by the Vaughan Williams classification system as class Ia. (Wikipedia)

   

Quifenadine

{1-azabicyclo[2.2.2]octan-2-yl}diphenylmethanol

C20H23NO (293.178)


Quifenadine is a second-generation H1-antihistamine.

   

3,4,5-Trihydroxypentanoylcarnitine

3-[(3,4,5-trihydroxypentanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C12H23NO7 (293.1474)


3,4,5-trihydroxypentanoylcarnitine is an acylcarnitine. More specifically, it is an 3,4,5-trihydroxypentanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 3,4,5-trihydroxypentanoylcarnitine is therefore classified as a short chain AC. As a short-chain acylcarnitine 3,4,5-trihydroxypentanoylcarnitine is a member of the most abundant group of carnitines in the body, comprising more than 50\\% of all acylcarnitines quantified in tissues and biofluids (PMID: 31920980). Some short-chain carnitines have been studied as supplements or treatments for a number of diseases, including neurological disorders and inborn errors of metabolism. Carnitine acetyltransferase (CrAT, EC:2.3.1.7) is responsible for the synthesis of all short-chain and short branched-chain acylcarnitines (PMID: 23485643). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(Z)-10-Hydroxyamitriptyline

2-[3-(dimethylamino)propylidene]tricyclo[9.4.0.0^{3,8}]pentadeca-1(15),3,5,7,11,13-hexaen-9-ol

C20H23NO (293.178)


   

[1,1'-Biphenyl]-4-carbonitrile, 4'-(heptyloxy)-

[1,1-Biphenyl]-4-carbonitrile, 4-(heptyloxy)-

C20H23NO (293.178)


   

Amitraz

N-(2,4-dimethylphenyl)-N-{[(2,4-dimethylphenyl)imino]methyl}-N-methylmethanimidamide

C19H23N3 (293.1892)


D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D010575 - Pesticides > D010574 - Pesticide Synergists D010575 - Pesticides > D007302 - Insect Repellents D010575 - Pesticides > D007306 - Insecticides D020011 - Protective Agents D016573 - Agrochemicals Amitraz is a non-systemic acaricide and insecticide with alpha-adrenergic agonist activity that interacts with octopamine receptors in the central nervous system and inhibits monoamine oxidase and prostaglandin synthesis.

   

Amitriptylinoxide

N,N-dimethyl-3-{tricyclo[9.4.0.0^{3,8}]pentadeca-1(15),3,5,7,11,13-hexaen-2-ylidene}propanamine oxide

C20H23NO (293.178)


C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent

   

Binedaline

N-[2-(dimethylamino)ethyl]-N-methyl-3-phenyl-1H-indol-1-amine

C19H23N3 (293.1892)


C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent

   

Budipine

4,4-Diphenyl-1-tert-butylpiperidine hydrochloride

C21H27N (293.2143)


D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents N - Nervous system > N04 - Anti-parkinson drugs > N04B - Dopaminergic agents C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent C93038 - Cation Channel Blocker Budipine is an anti-parkinson agent. Budipine also is a substrate of P-glycoprotein (P-gp), is mediated the uptake into the brain by P-gp. Budipine also is N-methyl-d-aspartate (NMDA) antagonist, and has indirect dopaminergic effects through an improved dopamine release, the inhibition of monoamine oxidase type B (MAO-B). Budipine can be used for the research of CNS disorders include Parkinson disease[1].

   

Butriptyline

dimethyl(2-methyl-3-{tricyclo[9.4.0.0³,⁸]pentadeca-1(15),3,5,7,11,13-hexaen-2-yl}propyl)amine

C21H27N (293.2143)


N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants > N06AA - Non-selective monoamine reuptake inhibitors D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent

   

3-(1-Adamantyl)-4-methyl-5-phenyl-1,2,4-triazole

3-(adamantan-1-yl)-4-methyl-5-phenyl-4H-1,2,4-triazole

C19H23N3 (293.1892)


   

Acridine carboxamide

N-[2-(Dimethylamino)ethyl]acridine-4-carboximidate

C18H19N3O (293.1528)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D004791 - Enzyme Inhibitors

   

Dimethylaminoparthenolide

12-[(dimethylamino)methyl]-4,8-dimethyl-3,14-dioxatricyclo[9.3.0.0^{2,4}]tetradec-7-en-13-one

C17H27NO3 (293.1991)


   

Embutramide

N-(2-(3-Methoxyphenyl)-2-ethylbutyl-(1))-gamma-hydroxybutyramide

C17H27NO3 (293.1991)


C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent

   

Levoprotiline

1-(methylamino)-3-{tetracyclo[6.6.2.0^{2,7}.0^{9,14}]hexadeca-2,4,6,9,11,13-hexaen-1-yl}propan-2-ol

C20H23NO (293.178)


   

Piperidine, 1-(4,4-diphenylbutyl)-

Piperidine, 1-(4,4-diphenylbutyl)-

C21H27N (293.2143)


   

(9Z)-(13S)-12,13-epoxyoctadeca-9,11-dienoate

(9Z)-(13S)-12,13-Epoxyoctadeca-9,11-dienoic acid

C18H29O3 (293.2117)


(9z)-(13s)-12,13-epoxyoctadeca-9,11-dienoate is practically insoluble (in water) and a weakly acidic compound (based on its pKa). (9z)-(13s)-12,13-epoxyoctadeca-9,11-dienoate can be found in a number of food items such as pomes, grape, butternut, and half-highbush blueberry, which makes (9z)-(13s)-12,13-epoxyoctadeca-9,11-dienoate a potential biomarker for the consumption of these food products.

   

3-oxo-2-(cis-2'-pentenyl)-cyclopentane-1-octanoate

3-oxo-2-(cis-2-Pentenyl)-cyclopentane-1-octanoic acid

C18H29O3 (293.2117)


3-oxo-2-(cis-2-pentenyl)-cyclopentane-1-octanoate is practically insoluble (in water) and a weakly acidic compound (based on its pKa). 3-oxo-2-(cis-2-pentenyl)-cyclopentane-1-octanoate can be found in a number of food items such as lemon grass, fireweed, pepper (c. pubescens), and pili nut, which makes 3-oxo-2-(cis-2-pentenyl)-cyclopentane-1-octanoate a potential biomarker for the consumption of these food products.

   

Lysyl-Phenylalanine

2-[(2,6-diamino-1-hydroxyhexylidene)amino]-3-phenylpropanoic acid

C15H23N3O3 (293.1739)


   

stephenanthrine

Phenanthro(3,4-d)-1,3-dioxole-5-ethanamine, N,N-dimethyl-

C19H19NO2 (293.1416)


   

4-(2-hydroxy-5,7-dimethyl-4-oxo6,8-nonadienyl)-2,6-piperidinedione

4-(2-hydroxy-5,7-dimethyl-4-oxo6,8-nonadienyl)-2,6-piperidinedione

C16H23NO4 (293.1627)


   
   

11-Hydroxy-6-methyl-5,3a-(iminopropano)spiro[tetrahydrofuran-2,3-hydrindane]-2,4-dione

11-Hydroxy-6-methyl-5,3a-(iminopropano)spiro[tetrahydrofuran-2,3-hydrindane]-2,4-dione

C16H23NO4 (293.1627)


   
   
   

Dehydronuciferine

15,16-dimethoxy-10-methyl-10-azatetracyclo[7.7.1.0^{2,7}.0^{13,17}]heptadeca-1(16),2,4,6,8,13(17),14-heptaene

C19H19NO2 (293.1416)


Dehydronuciferine is isolated from the leaves of Nelumbo nucifera Gaertn, a acetylcholinesterase (AChE) inhibitor with an IC50 of 25 μg/mL[1]. Dehydronuciferine is isolated from the leaves of Nelumbo nucifera Gaertn, a acetylcholinesterase (AChE) inhibitor with an IC50 of 25 μg/mL[1].

   

2-(3,4-Dimethoxyphenylethyl)quinoline

2-(3,4-Dimethoxyphenylethyl)quinoline

C19H19NO2 (293.1416)


   
   

venlafaxine n-oxide

venlafaxine n-oxide

C17H27NO3 (293.1991)


CONFIDENCE standard compound; EAWAG_UCHEM_ID 3396 CONFIDENCE standard compound; INTERNAL_ID 2121

   

Maybridge3_004872

Maybridge3_004872

C17H27NO3 (293.1991)


   

Prozapine

Prozapine

C21H27N (293.2143)


C78272 - Agent Affecting Nervous System > C29698 - Antispasmodic Agent

   
   

substance FKI-1938A

substance FKI-1938A

C19H19NO2 (293.1416)


   

lannotinidine E

lannotinidine E

C16H23NO4 (293.1627)


   
   

8-methoxy-3,3,9-trimethyl-3,11-dihydro-pyrano[3,2-a]carbazole|Koenimbin

8-methoxy-3,3,9-trimethyl-3,11-dihydro-pyrano[3,2-a]carbazole|Koenimbin

C19H19NO2 (293.1416)


   

sessilifoliamide B

sessilifoliamide B

C17H27NO3 (293.1991)


   

pyrayafoline|Pyrayafoline A|Pyrayafoline-A

pyrayafoline|Pyrayafoline A|Pyrayafoline-A

C19H19NO2 (293.1416)


   

Clauszoline H

Clauszoline H

C19H19NO2 (293.1416)


   

3-Hydroxy-2-oxodendrobine

3-Hydroxy-2-oxodendrobine

C16H23NO4 (293.1627)


   

5-methoxy-3,3,8-trimethyl-3,11-dihydro-pyrano[3,2-a]carbazole|Heptazolidine

5-methoxy-3,3,8-trimethyl-3,11-dihydro-pyrano[3,2-a]carbazole|Heptazolidine

C19H19NO2 (293.1416)


   

2-(3,4-Dimethoxyphenethyl)quinoline

2-(3,4-Dimethoxyphenethyl)quinoline

C19H19NO2 (293.1416)


   

AKOS034145070

AKOS034145070

C16H23NO4 (293.1627)


   

(2E,7E,9E)-N-(2-hydroxy-2-methylpropyl)-6,11-dioxo-2,7,9-dodecatrienamide

(2E,7E,9E)-N-(2-hydroxy-2-methylpropyl)-6,11-dioxo-2,7,9-dodecatrienamide

C16H23NO4 (293.1627)


   
   

COC1=C(C=2NC3=CC=CC=C3C=2C=C1C=O)C=CC(C)C

COC1=C(C=2NC3=CC=CC=C3C=2C=C1C=O)C=CC(C)C

C19H19NO2 (293.1416)


   

daphenylline

daphenylline

C21H27N (293.2143)


   

N,N-di(methoxycarbonylethyl)-2,6-dimethylaniline

N,N-di(methoxycarbonylethyl)-2,6-dimethylaniline

C16H23NO4 (293.1627)


   
   

6,6a-dihydrodemethoxyguadiscine

6,6a-dihydrodemethoxyguadiscine

C19H19NO2 (293.1416)


   
   

Heptaphylline

Heptaphylline

C19H19NO2 (293.1416)


   

7-Methoxyglycomaurin

7-Methoxyglycomaurin

C19H19NO2 (293.1416)


   

N-[2-(1H-indol-3-yl)ethyl]-2-(methylamino)benzamide

N-[2-(1H-indol-3-yl)ethyl]-2-(methylamino)benzamide

C18H19N3O (293.1528)


   
   
   

O-Methylmurrayamine A

O-Methylmurrayamine A

C19H19NO2 (293.1416)


   
   
   

L-Phenylalanine, N-(N-glycyl-L-alanyl)-

L-Phenylalanine, N-(N-glycyl-L-alanyl)-

C14H19N3O4 (293.1375)


   
   

a jasmonoyl-1-aminocyclopropane-1 carboxylate

a jasmonoyl-1-aminocyclopropane-1 carboxylate

C16H23NO4 (293.1627)


   

Anastrozole

Anastrozole

C17H19N5 (293.164)


L - Antineoplastic and immunomodulating agents > L02 - Endocrine therapy > L02B - Hormone antagonists and related agents > L02BG - Aromatase inhibitors D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D065088 - Steroid Synthesis Inhibitors D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D004965 - Estrogen Antagonists C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D004791 - Enzyme Inhibitors > D065088 - Steroid Synthesis Inhibitors > D047072 - Aromatase Inhibitors C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1740 - Aromatase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist D000970 - Antineoplastic Agents

   

STEPHENANTHRINE

NCGC00160247-01!STEPHENANTHRINE

C19H19NO2 (293.1416)


   

Nonivamide

Nonanamide, N-[(4-hydroxy-3-methoxyphenyl)methyl]-

C17H27NO3 (293.1991)


CONFIDENCE standard compound; INTERNAL_ID 964; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4374; ORIGINAL_PRECURSOR_SCAN_NO 4372 CONFIDENCE standard compound; INTERNAL_ID 964; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4385; ORIGINAL_PRECURSOR_SCAN_NO 4381 CONFIDENCE standard compound; INTERNAL_ID 964; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4393; ORIGINAL_PRECURSOR_SCAN_NO 4390 CONFIDENCE standard compound; INTERNAL_ID 964; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4393; ORIGINAL_PRECURSOR_SCAN_NO 4391 CONFIDENCE standard compound; INTERNAL_ID 964; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9273; ORIGINAL_PRECURSOR_SCAN_NO 9269 CONFIDENCE standard compound; INTERNAL_ID 964; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9289; ORIGINAL_PRECURSOR_SCAN_NO 9288 CONFIDENCE standard compound; INTERNAL_ID 964; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9279; ORIGINAL_PRECURSOR_SCAN_NO 9277 CONFIDENCE standard compound; INTERNAL_ID 964; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9286; ORIGINAL_PRECURSOR_SCAN_NO 9284 CONFIDENCE standard compound; INTERNAL_ID 964; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9306; ORIGINAL_PRECURSOR_SCAN_NO 9303 CONFIDENCE standard compound; INTERNAL_ID 964; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9298; ORIGINAL_PRECURSOR_SCAN_NO 9296 CONFIDENCE standard compound; INTERNAL_ID 8335 Nonivamide is a

   

VEN_294.2063_13.1

VEN_294.2063_13.1

C17H27NO3 (293.1991)


INTERNAL_ID 1902; CONFIDENCE Transformation product with Reference Standard (Level 1) CONFIDENCE Transformation product with Reference Standard (Level 1); INTERNAL_ID 1902

   

C14H19N3O4_N~5~-Carbamoyl-N~2~-(phenylacetyl)ornithine

NCGC00385854-01_C14H19N3O4_N~5~-Carbamoyl-N~2~-(phenylacetyl)ornithine

C14H19N3O4 (293.1375)


   

ondansetron

Ondansetron aka "9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1H-carbazol-4-one"

C18H19N3O (293.1528)


A - Alimentary tract and metabolism > A04 - Antiemetics and antinauseants > A04A - Antiemetics and antinauseants > A04AA - Serotonin (5ht3) antagonists C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist > C94726 - 5-HT3 Receptor Antagonist D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D003879 - Dermatologic Agents > D000982 - Antipruritics D002491 - Central Nervous System Agents Ondansetron (GR 38032; SN 307) is a highly selective 5-HT3 receptor antagonist, with IC50 value of 103 pM. Ondansetron exerts antiemetic effects by antagonizing 5-HT receptor located on local neurons in the peripheral and central nervous system. Ondansetron suppresses nausea and vomiting caused by chemotherapy and radiation therapy. Ondansetron has orally bioactivity[1][2][3][4][5][6][7][8].

   

3,4,5,6-tetradehydrogeissoschizol

3,4,5,6-tetradehydrogeissoschizol

[C19H21N2O]+ (293.1654)


   

N-Fructosyl isoleucine

N-Fructosyl isoleucine

C12H23NO7 (293.1474)


Annotation level-3

   

Fabesetron

Fabesetron

C18H19N3O (293.1528)


C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist > C94726 - 5-HT3 Receptor Antagonist CONFIDENCE standard compound; INTERNAL_ID 393; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3660; ORIGINAL_PRECURSOR_SCAN_NO 3659 CONFIDENCE standard compound; INTERNAL_ID 393; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3638; ORIGINAL_PRECURSOR_SCAN_NO 3636 CONFIDENCE standard compound; INTERNAL_ID 393; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3651; ORIGINAL_PRECURSOR_SCAN_NO 3649 CONFIDENCE standard compound; INTERNAL_ID 393; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3679; ORIGINAL_PRECURSOR_SCAN_NO 3675 CONFIDENCE standard compound; INTERNAL_ID 393; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3688; ORIGINAL_PRECURSOR_SCAN_NO 3687 DATASET 20200303_ENTACT_RP_MIX505; CONFIDENCE standard compound; INTERNAL_ID 393; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3974; ORIGINAL_PRECURSOR_SCAN_NO 3970 CONFIDENCE standard compound; INTERNAL_ID 393; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3974; ORIGINAL_PRECURSOR_SCAN_NO 3970 CONFIDENCE standard compound; INTERNAL_ID 393; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8035; ORIGINAL_PRECURSOR_SCAN_NO 8033 INTERNAL_ID 393; CONFIDENCE standard compound; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8035; ORIGINAL_PRECURSOR_SCAN_NO 8033 CONFIDENCE standard compound; INTERNAL_ID 393; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8049; ORIGINAL_PRECURSOR_SCAN_NO 8045 CONFIDENCE standard compound; INTERNAL_ID 393; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8030; ORIGINAL_PRECURSOR_SCAN_NO 8029 CONFIDENCE standard compound; INTERNAL_ID 393; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8041; ORIGINAL_PRECURSOR_SCAN_NO 8036 CONFIDENCE standard compound; INTERNAL_ID 393; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8063; ORIGINAL_PRECURSOR_SCAN_NO 8062 CONFIDENCE standard compound; INTERNAL_ID 393; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7948; ORIGINAL_PRECURSOR_SCAN_NO 7944

   

Levoprtiline

Hydroxymaprotiline

C20H23NO (293.178)


   

3-Hydroxymaprotiline

3-Hydroxymaprotiline

C20H23NO (293.178)


   

2-Hydroxymaprotiline

2-Hydroxymaprotiline

C20H23NO (293.178)


   
   

1,2,3,4-Tetrahydro-2-[(isopropylamino)methyl]-7-nitro-6-quinolinecarboxylic acid

1,2,3,4-Tetrahydro-2-[(isopropylamino)methyl]-7-nitro-6-quinolinecarboxylic acid

C14H19N3O4 (293.1375)


   
   
   
   
   

Cyclic dinorpropoxyphene

Cyclic dinorpropoxyphene

C20H23NO (293.178)


   
   
   
   
   

(5R,E)-6-((7R,8R,E)-7,8-dihydroxy-8-methylhexahydroindolizin-6(5H)-ylidene)-2,5-dimethylhex-2-enal

(5R,E)-6-((7R,8R,E)-7,8-dihydroxy-8-methylhexahydroindolizin-6(5H)-ylidene)-2,5-dimethylhex-2-enal

C17H27NO3 (293.1991)


   

5-Hepten-3-yn-1-ol, 2,2-dimethyl-7-[(1-naphthalenylmethyl)amino]-, (E)-

5-Hepten-3-yn-1-ol, 2,2-dimethyl-7-[(1-naphthalenylmethyl)amino]-, (E)-

C20H23NO (293.178)


   

desmethyldihydrocapsaicin

desmethyldihydrocapsaicin

C17H27NO3 (293.1991)


   

CAY10398

4-(dimethylamino)-N-[6-(hydroxyamino)-6-oxohexyl]-benzamide

C15H23N3O3 (293.1739)


   

GLN-Phe

2-(2-amino-3-phenylpropanamido)-4-carbamoylbutanoic acid

C14H19N3O4 (293.1375)


   

Lys-phe

6-amino-2-(2-amino-3-phenylpropanamido)hexanoic acid

C15H23N3O3 (293.1739)


A dipeptide formed from L-lysine and L-phenylalanine residues.

   

Phe-GLN

2-(2-amino-4-carbamoylbutanamido)-3-phenylpropanoic acid

C14H19N3O4 (293.1375)


   

Phe-lys

2-(2,6-diaminohexanamido)-3-phenylpropanoic acid

C15H23N3O3 (293.1739)


   

Phe-gglu

2-[2-amino-4-(C-hydroxycarbonimidoyl)butanamido]-3-phenylpropanoic acid

C14H19N3O4 (293.1375)


   

GGlu-Phe

2-(2-amino-3-phenylpropanamido)-4-(C-hydroxycarbonimidoyl)butanoic acid

C14H19N3O4 (293.1375)


   

Koenimbin

13-methoxy-5,5,8-trimethyl-6-oxa-17-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1,3,7,9,11,13,15-heptaene

C19H19NO2 (293.1416)


   

Nordihydrocapsacin

N-[(4-Hydroxy-3-methoxyphenyl)methyl]-7-methyloctanamide, 9CI

C17H27NO3 (293.1991)


Nordihydrocapsaicin is a capsaicinoid analog and congener of capsaicin in chili peppers[1]. Nordihydrocapsaicin is a capsaicinoid analog and congener of capsaicin in chili peppers[1].

   

Dihydrolevobunolol

Dihydrolevobunolol

C17H27NO3 (293.1991)


   

10-Hydroxyamitriptyline

10-Hydroxyamitriptyline

C20H23NO (293.178)


   

9H-Carbazole-3-boronic acid pinacol ester

9H-Carbazole-3-boronic acid pinacol ester

C18H20BNO2 (293.1587)


   
   

2-(2-AMINOPHENYL)-5-(4-(TERT-BUTYL)PHENYL)-1,3,4-OXADIAZOLE

2-(2-AMINOPHENYL)-5-(4-(TERT-BUTYL)PHENYL)-1,3,4-OXADIAZOLE

C18H19N3O (293.1528)


   

1,2-diethenylbenzene: N,N-dimethylmethanamine: styrene

1,2-diethenylbenzene: N,N-dimethylmethanamine: styrene

C21H27N (293.2143)


   

(3S,4S)-TERT-BUTYL 3-HYDROXY-4-(4-HYDROXYPHENYL)PIPERIDINE-1-CARBOXYLATE

(3S,4S)-TERT-BUTYL 3-HYDROXY-4-(4-HYDROXYPHENYL)PIPERIDINE-1-CARBOXYLATE

C16H23NO4 (293.1627)


   

2-(1,3-benzoxazol-2-yl)-1-(4-tert-butylphenyl)ethanone

2-(1,3-benzoxazol-2-yl)-1-(4-tert-butylphenyl)ethanone

C19H19NO2 (293.1416)


   

3,5-Dip-tolyl-4,5-dihydro-1H-pyrazole-1-carboxamide

3,5-Dip-tolyl-4,5-dihydro-1H-pyrazole-1-carboxamide

C18H19N3O (293.1528)


   

(S)-(3B,12B)-12,20-DIHYDROXYDAMMAR-24-EN-3-YLBETA-D-GLUCOPYRANOSIDE

(S)-(3B,12B)-12,20-DIHYDROXYDAMMAR-24-EN-3-YLBETA-D-GLUCOPYRANOSIDE

C16H23NO4 (293.1627)


   

N-Lauroylsarcosine sodium salt

N-Lauroylsarcosine sodium salt

C15H28NNaO3 (293.1967)


   

CHEMBRDG-BB 4011737

CHEMBRDG-BB 4011737

C16H23NO4 (293.1627)


   

(1-Furan-2-yl-2-phenyl-ethyl)-(4-methoxy-phenyl)-amine

(1-Furan-2-yl-2-phenyl-ethyl)-(4-methoxy-phenyl)-amine

C19H19NO2 (293.1416)


   

Ethyl [3-(triethoxysilyl)propyl]carbamate

Ethyl [3-(triethoxysilyl)propyl]carbamate

C12H27NO5Si (293.1658)


   

dimazole

Diamthazole

C15H23N3OS (293.1562)


D - Dermatologicals > D01 - Antifungals for dermatological use > D01A - Antifungals for topical use C254 - Anti-Infective Agent > C514 - Antifungal Agent

   

(S)-2-((tert-Butoxycarbonyl)amino)-5-phenylpentanoic acid

(S)-2-((tert-Butoxycarbonyl)amino)-5-phenylpentanoic acid

C16H23NO4 (293.1627)


   

boc-d-2-amino-5-phenyl-pentanoic acid dcha salt

boc-d-2-amino-5-phenyl-pentanoic acid dcha salt

C16H23NO4 (293.1627)


   

N-(4-Cyclohexylphenyl)-4-isopropylbenzenamine

N-(4-Cyclohexylphenyl)-4-isopropylbenzenamine

C21H27N (293.2143)


   

3-AMINO-3-(3,5-DI-TERT-BUTYL-4-HYDROXY-PHENYL)-PROPIONIC ACID

3-AMINO-3-(3,5-DI-TERT-BUTYL-4-HYDROXY-PHENYL)-PROPIONIC ACID

C17H27NO3 (293.1991)


   

Levoprotiline

Levoprotiline

C20H23NO (293.178)


   

2-N-BOC-2-AMINOMETHYL-3-M-TOLYL-PROPIONIC ACID

2-N-BOC-2-AMINOMETHYL-3-M-TOLYL-PROPIONIC ACID

C16H23NO4 (293.1627)


   

2-N-BOC-2-AMINOMETHYL-3-P-TOLYL-PROPIONIC ACID

2-N-BOC-2-AMINOMETHYL-3-P-TOLYL-PROPIONIC ACID

C16H23NO4 (293.1627)


   

(E)-10-Hydroxyamitriptyline

amitriptyline metabolite (+/-)-

C20H23NO (293.178)


   

azane,2-ethyl-2-(hydroxymethyl)propane-1,3-diol,furan-2,5-dione,oxirane

azane,2-ethyl-2-(hydroxymethyl)propane-1,3-diol,furan-2,5-dione,oxirane

C12H23NO7 (293.1474)


   

(R)-4-((TERT-BUTOXYCARBONYL)AMINO)-5-PHENYLPENTANOIC ACID

(R)-4-((TERT-BUTOXYCARBONYL)AMINO)-5-PHENYLPENTANOIC ACID

C16H23NO4 (293.1627)


   

(S)-METHYL3-(4-HYDROXY-3-NITROPHENYL)-2-(2,2,2-TRIFLUOROACETYLAMINO)PROPIONATE

(S)-METHYL3-(4-HYDROXY-3-NITROPHENYL)-2-(2,2,2-TRIFLUOROACETYLAMINO)PROPIONATE

C19H19NO2 (293.1416)


   

TERT-BUTYL 3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-PYRROLE-1-CARBOXYLATE

TERT-BUTYL 3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-PYRROLE-1-CARBOXYLATE

C15H24BNO4 (293.1798)


   

Spiro[2H-1-benzopyran-2,2-[2H]indol]-6-ol,1,3-dihydro-1,3,3-trimethyl-

Spiro[2H-1-benzopyran-2,2-[2H]indol]-6-ol,1,3-dihydro-1,3,3-trimethyl-

C19H19NO2 (293.1416)


   

(2-((tert-Butyldimethylsilyloxy)methyl)furo[3,2-b]pyridin-6-yl)methanol

(2-((tert-Butyldimethylsilyloxy)methyl)furo[3,2-b]pyridin-6-yl)methanol

C15H23NO3Si (293.1447)


   

(8R,9S,13S,14S,17S)-16,16,17-trideuterio-13-methyl-6,7,8,9,11,12,14,15-octahydrocyclopenta[a]phenanthrene-3,4,17-triol

(8R,9S,13S,14S,17S)-16,16,17-trideuterio-13-methyl-6,7,8,9,11,12,14,15-octahydrocyclopenta[a]phenanthrene-3,4,17-triol

C18H19D5O3 (293.2039)


   

Boc-L-2,4-dimethylphe

Boc-L-2,4-dimethylphe

C16H23NO4 (293.1627)


   

Boc-D-2,4-dimethylphe

Boc-D-2,4-dimethylphe

C16H23NO4 (293.1627)


   

N-Octylglucamine

N-Octylglucamine

C14H31NO5 (293.2202)


   

methyl (E)-3-[2-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]prop-2-enoate

methyl (E)-3-[2-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]prop-2-enoate

C16H23NO4 (293.1627)


   

Nafenodone

Nafenodone

C20H23NO (293.178)


   

tert-butyl-dimethyl-(1-methylsulfonylpiperidin-4-yl)oxysilane

tert-butyl-dimethyl-(1-methylsulfonylpiperidin-4-yl)oxysilane

C12H27NO3SSi (293.1481)


   

Boc-(R)-3-Amino-4-(4-methylphenyl)-butyric acid

Boc-(R)-3-Amino-4-(4-methylphenyl)-butyric acid

C16H23NO4 (293.1627)


   

2-(AMINOMETHYL)-18-CROWN-6

2-(AMINOMETHYL)-18-CROWN-6

C13H27NO6 (293.1838)


   

5-AMINO-DI-T-BUTYL ISOPHTHALATE

5-AMINO-DI-T-BUTYL ISOPHTHALATE

C16H23NO4 (293.1627)


   

Phosphonic acid,[(diethylamino)carbonyl]-, dibutyl ester (9CI)

Phosphonic acid,[(diethylamino)carbonyl]-, dibutyl ester (9CI)

C13H28NO4P (293.1756)


   

4-FLUORO-2-METHOXYPHENYLBORONICACID

4-FLUORO-2-METHOXYPHENYLBORONICACID

C16H23NO4 (293.1627)


   

(17β)-(17-2H)Estra-1(10),2,4-triene-2,3,17-triol

(17β)-(17-2H)Estra-1(10),2,4-triene-2,3,17-triol

C18H19D5O3 (293.2039)


   

5-tert-butyl-2-(2-ethylhexylsulfanyl)aniline

5-tert-butyl-2-(2-ethylhexylsulfanyl)aniline

C18H31NS (293.2177)


   

1-(2,4-dinitrophenyl)-4-propyl-piperidine

1-(2,4-dinitrophenyl)-4-propyl-piperidine

C14H19N3O4 (293.1375)


   

Streptimidone

Streptimidone

C16H23NO4 (293.1627)


   

2,4-DiMorpholinonitrobenzene

2,4-DiMorpholinonitrobenzene

C14H19N3O4 (293.1375)


   

(4-{[(2-Methyl-2-propanyl)oxy]carbonyl}-2,3,4,5-tetrahydro-1,4-be nzoxazepin-7-yl)boronic acid

(4-{[(2-Methyl-2-propanyl)oxy]carbonyl}-2,3,4,5-tetrahydro-1,4-be nzoxazepin-7-yl)boronic acid

C14H20BNO5 (293.1434)


   

3-(4-FLUORO-PHENYLCARBAMOYL)-1,2,2-TRIMETHYL-CYCLOPENTANECARBOXYLIC ACID

3-(4-FLUORO-PHENYLCARBAMOYL)-1,2,2-TRIMETHYL-CYCLOPENTANECARBOXYLIC ACID

C16H20FNO3 (293.1427)


   

1-BOC-pyrrole-2-boronic acid, pinacol ester

1-BOC-pyrrole-2-boronic acid, pinacol ester

C15H24BNO4 (293.1798)


   

9H-Carbazole-2-boronic acid pinacol ester

9H-Carbazole-2-boronic acid pinacol ester

C18H20BNO2 (293.1587)


   

(1S,2S)-BOC-2-AMINOCYCLOPENTANECARBOXYLICACID

(1S,2S)-BOC-2-AMINOCYCLOPENTANECARBOXYLICACID

C17H27NO3 (293.1991)


   

Boc-(R)-3-amino-4-(2-methylphenyl)-butyric acid

Boc-(R)-3-amino-4-(2-methylphenyl)-butyric acid

C16H23NO4 (293.1627)


   

Boc-(S)-3-Amino-4-(3-methyl-phenyl)-butyric acid

Boc-(S)-3-Amino-4-(3-methyl-phenyl)-butyric acid

C16H23NO4 (293.1627)


   

Boc-(S)-3-Amino-4-(4-methyl-phenyl)-butyric acid

Boc-(S)-3-Amino-4-(4-methyl-phenyl)-butyric acid

C16H23NO4 (293.1627)


   

Boc-(S)-3-Amino-5-phenylpentanoic acid

Boc-(S)-3-Amino-5-phenylpentanoic acid

C16H23NO4 (293.1627)


   

BENZYL ((S)-1-HYDROXY-3-((R)-TETRAHYDRO-2H-PYRAN-3-YL)PROPAN-2-YL)CARBAMATE

BENZYL ((S)-1-HYDROXY-3-((R)-TETRAHYDRO-2H-PYRAN-3-YL)PROPAN-2-YL)CARBAMATE

C16H23NO4 (293.1627)


   

4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohex-3-en-1-yl]morpholine

4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohex-3-en-1-yl]morpholine

C16H28BNO3 (293.2162)


   

(2R)-2-[Bis(3,5-dimethylphenyl)methyl]pyrrolidine

(2R)-2-[Bis(3,5-dimethylphenyl)methyl]pyrrolidine

C21H27N (293.2143)


   

(S)-2-[Bis(3,5-dimethylphenyl)methyl]pyrrolidine

(S)-2-[Bis(3,5-dimethylphenyl)methyl]pyrrolidine

C21H27N (293.2143)


   

BETA-[[(1,1-DIMETHYLETHOXY)CARBONYL]AMINO]-BENZENEBUTANOIC ACID METHYL ESTER

BETA-[[(1,1-DIMETHYLETHOXY)CARBONYL]AMINO]-BENZENEBUTANOIC ACID METHYL ESTER

C16H23NO4 (293.1627)


   

H-Gly-Phe-Ala-OH

H-Gly-Phe-Ala-OH

C14H19N3O4 (293.1375)


   

H-Gly-Ala-Phe-OH

H-Gly-Ala-Phe-OH

C14H19N3O4 (293.1375)


   

CIS-STILBENEBORONIC ACID DIETHANOLAMINE ESTER

CIS-STILBENEBORONIC ACID DIETHANOLAMINE ESTER

C18H20BNO2 (293.1587)


   

4-Nitrophenyl decanoate

4-Nitrophenyl decanoate

C16H23NO4 (293.1627)


   

TERT-BUTYL 5-PHENYL-1H-INDOLE-1-CARBOXYLATE

TERT-BUTYL 5-PHENYL-1H-INDOLE-1-CARBOXYLATE

C19H19NO2 (293.1416)


   

L-Lysine L-glutamate

L-Lysine L-glutamate

C11H23N3O6 (293.1587)


   

1-BENZYL-2,3-DIMETHYL-1H-INDOLE-5-CARBOHYDRAZIDE

1-BENZYL-2,3-DIMETHYL-1H-INDOLE-5-CARBOHYDRAZIDE

C18H19N3O (293.1528)


   

Sodium N-dodecanoyl-L-alaninate

Sodium N-dodecanoyl-L-alaninate

C15H28NNaO3 (293.1967)


   

Methyl 2-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)nicotinate

Methyl 2-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)nicotinate

C14H20BNO5 (293.1434)


   

N,N-DIETHYL-4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-PYRAZOLE-1-ETHANAMINE

N,N-DIETHYL-4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-PYRAZOLE-1-ETHANAMINE

C15H28BN3O2 (293.2274)


   

2-Benzylidene isobutyryl acetanilide

2-Benzylidene isobutyryl acetanilide

C19H19NO2 (293.1416)


   

PIPERIDINE-1,4-DIYLBIS(PHENYLMETHANONE)

PIPERIDINE-1,4-DIYLBIS(PHENYLMETHANONE)

C19H19NO2 (293.1416)


   

N-BOC-3-(4-FLUOROBENZYL)PIPERIDINE

N-BOC-3-(4-FLUOROBENZYL)PIPERIDINE

C17H24FNO2 (293.1791)


   

BENZYL-[1-(4-CYCLOHEXYLPHENYL)ETHYL]AMINE

BENZYL-[1-(4-CYCLOHEXYLPHENYL)ETHYL]AMINE

C21H27N (293.2143)


   

1,2-diphenyl-3-(1-piperidyl)propan-1-one

1,2-diphenyl-3-(1-piperidyl)propan-1-one

C20H23NO (293.178)


   

Dexnafenodone

Dexnafenodone

C20H23NO (293.178)


   

promolate

promolate

C16H23NO4 (293.1627)


C78272 - Agent Affecting Nervous System > C29698 - Antispasmodic Agent

   

2-PYRIDIN-2-YLMALONIC ACID DI-TERT-BUTYL ESTER

2-PYRIDIN-2-YLMALONIC ACID DI-TERT-BUTYL ESTER

C16H23NO4 (293.1627)


   

1-(1-benzylpiperidin-4-yl)-2-phenylethanone

1-(1-benzylpiperidin-4-yl)-2-phenylethanone

C20H23NO (293.178)


   

1-[2-(3,5-dimethylphenoxy)ethyl]indole-3-carbaldehyde

1-[2-(3,5-dimethylphenoxy)ethyl]indole-3-carbaldehyde

C19H19NO2 (293.1416)


   

6-(4-ISOPROPOXY-BENZOYLAMINO)-HEXANOIC ACID

6-(4-ISOPROPOXY-BENZOYLAMINO)-HEXANOIC ACID

C16H23NO4 (293.1627)


   

N-(4-FLUORO-2-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)BENZYL)PROPAN-1-AMINE

N-(4-FLUORO-2-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)BENZYL)PROPAN-1-AMINE

C16H25BFNO2 (293.1962)


   

α,α-Bis[2-(diMethylaMino)ethyl]-

α,α-Bis[2-(diMethylaMino)ethyl]-

C16H24ClN3 (293.1659)


   

4-Cyanophenyl 4-pentylbenzoate

4-Cyanophenyl 4-pentylbenzoate

C19H19NO2 (293.1416)


   

Boc-(R)-3-Amino-5-phenylpentanoic acid

Boc-(R)-3-Amino-5-phenylpentanoic acid

C16H23NO4 (293.1627)


   

ABT-724

2-[(4-pyridin-2-ylpiperazin-1-yl)methyl]-1H-benzimidazole

C17H19N5 (293.164)


   

di-n-butyl 4-aminophthalate

di-n-butyl 4-aminophthalate

C16H23NO4 (293.1627)


   

1-[1-[(4-Chlorophenyl)Methyl]-4-piperidinyl] piperazine

1-[1-[(4-Chlorophenyl)Methyl]-4-piperidinyl] piperazine

C16H24ClN3 (293.1659)


   

Methyl (3R)-(-)-3-(methyl-1H-Indol-3-yl)-3-phenylpropanoate

Methyl (3R)-(-)-3-(methyl-1H-Indol-3-yl)-3-phenylpropanoate

C19H19NO2 (293.1416)


   

Methyl 7-isobutyl-1,3-diMethyl-2,4-dioxo-2,3,4,7-tetrahydro-1H-pyrrolo[2,3-d]pyriMidine-6-carboxylate

Methyl 7-isobutyl-1,3-diMethyl-2,4-dioxo-2,3,4,7-tetrahydro-1H-pyrrolo[2,3-d]pyriMidine-6-carboxylate

C14H19N3O4 (293.1375)


   

9-Amino(9-deoxy)epi-cinchoninetrihydrochloride

9-Amino(9-deoxy)epi-cinchoninetrihydrochloride

C19H23N3 (293.1892)


   

N-octyl-4-metylpyridinium tetrafluoroborate

N-octyl-4-metylpyridinium tetrafluoroborate

C14H24BF4N (293.1938)


   

Venlafaxine N-Oxide Impurity

Venlafaxine N-Oxide Impurity

C17H27NO3 (293.1991)


   

methyl5,5-dimethoxy-7,9-dimethyl-2,3,4,5-tetrahydro-1H-benzo[b]azepine-1-carboxylate

methyl5,5-dimethoxy-7,9-dimethyl-2,3,4,5-tetrahydro-1H-benzo[b]azepine-1-carboxylate

C16H23NO4 (293.1627)


   

Isobutyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrole-1-carboxylate

Isobutyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrole-1-carboxylate

C15H24BNO4 (293.1798)


   
   

2-(3-Methoxypropylamino)pyrimidine-5-boronic acid, pinacol ester

2-(3-Methoxypropylamino)pyrimidine-5-boronic acid, pinacol ester

C14H24BN3O3 (293.1911)


   

METHYL 4-[N-BENZYL-N-(2-ETHOXY-2-OXOETHYL)AMINO]BUTANOATE

METHYL 4-[N-BENZYL-N-(2-ETHOXY-2-OXOETHYL)AMINO]BUTANOATE

C16H23NO4 (293.1627)


   

Boc-(S)-3-Amino-4-(2-methyl-phenyl)-butyric acid

Boc-(S)-3-Amino-4-(2-methyl-phenyl)-butyric acid

C16H23NO4 (293.1627)


   

1-((5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)THIOPHEN-2-YL)METHYL)PYRROLIDINE

1-((5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)THIOPHEN-2-YL)METHYL)PYRROLIDINE

C15H24BNO2S (293.1621)


   

(R)-ETHYL1-METHYLPIPERIDINE-3-CARBOXYLATE

(R)-ETHYL1-METHYLPIPERIDINE-3-CARBOXYLATE

C19H19NO2 (293.1416)


   

(R)-tert-Butyl 2-(dimethylcarbamoyl)piperazine-1-carboxylate hydrochloride

(R)-tert-Butyl 2-(dimethylcarbamoyl)piperazine-1-carboxylate hydrochloride

C12H24ClN3O3 (293.1506)


   

5-[3-(dimethylamino)propyl]-5H-dibenzo[a,d]cyclohepten-5-ol

5-[3-(dimethylamino)propyl]-5H-dibenzo[a,d]cyclohepten-5-ol

C20H23NO (293.178)


   

BENZENEPROPANOIC ACID,-[2-[[(1,1-DIMETHYLETHOXY)CARBONYL]AMINO]ETHYL]-

BENZENEPROPANOIC ACID,-[2-[[(1,1-DIMETHYLETHOXY)CARBONYL]AMINO]ETHYL]-

C16H23NO4 (293.1627)


   

(2S)-2-acetamido-4-methyl-N-(4-nitrophenyl)pentanamide

(2S)-2-acetamido-4-methyl-N-(4-nitrophenyl)pentanamide

C14H19N3O4 (293.1375)


   

Boc-(R)-3-Amino-4-(3-methyl-phenyl)-butyric acid

Boc-(R)-3-Amino-4-(3-methyl-phenyl)-butyric acid

C16H23NO4 (293.1627)


   

4-(Dibenzylamino)cyclohexanone

4-(Dibenzylamino)cyclohexanone

C20H23NO (293.178)


   

Methyl 2-methoxy-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)nicotinate

Methyl 2-methoxy-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)nicotinate

C14H20BNO5 (293.1434)


   

2-(4-Ethoxy-3-nitrophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

2-(4-Ethoxy-3-nitrophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

C14H20BNO5 (293.1434)


   

(1-(TERT-BUTYLDIMETHYLSILYL)-5-FLUORO-1H-INDOL-4-YL)BORONIC ACID

(1-(TERT-BUTYLDIMETHYLSILYL)-5-FLUORO-1H-INDOL-4-YL)BORONIC ACID

C14H21BFNO2Si (293.1419)


   

N-(4-Methylbenzoyl)-4-Benzylpiperidine

N-(4-Methylbenzoyl)-4-Benzylpiperidine

C20H23NO (293.178)


   

2-Quinolineethanol, 4-(dimethylamino)-1,2,3,4-tetrahydro-beta,beta-dimethyl-6-nitro-

2-Quinolineethanol, 4-(dimethylamino)-1,2,3,4-tetrahydro-beta,beta-dimethyl-6-nitro-

C15H23N3O3 (293.1739)


   
   

Pramiverine

Pramiverine

C21H27N (293.2143)


C78272 - Agent Affecting Nervous System > C29698 - Antispasmodic Agent

   

Jasmonic acid/1-amino-1-cyclopropane carboxylic acid

Jasmonic acid/1-amino-1-cyclopropane carboxylic acid

C16H23NO4 (293.1627)


   

(Z)-10-Hydroxyamitriptyline

(Z)-10-Hydroxyamitriptyline

C20H23NO (293.178)


   

alpha,alpha-Diphenyl-2-quinuclidinemethanol

alpha,alpha-Diphenyl-2-quinuclidinemethanol

C20H23NO (293.178)


   

Piperidine, 1-(4,4-diphenylbutyl)-

Piperidine, 1-(4,4-diphenylbutyl)-

C21H27N (293.2143)


   

4-Phenyl-1-(4-phenylbutyl)piperidine

4-Phenyl-1-(4-phenylbutyl)piperidine

C21H27N (293.2143)


   

Octylhomovanillamide

Octylhomovanillamide

C17H27NO3 (293.1991)


   

H-Ala-Phe-Gly-OH

H-Ala-Phe-Gly-OH

C14H19N3O4 (293.1375)


   

(R)-6-Allyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol

(R)-6-Allyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol

C19H19NO2 (293.1416)


   

3-[(6-Methyl-4-phenyl-2-quinazolinyl)amino]-1-propanol

3-[(6-Methyl-4-phenyl-2-quinazolinyl)amino]-1-propanol

C18H19N3O (293.1528)


   

(4-Benzoyl-1-methyl-3-pyrrolidinyl)-phenylmethanone

(4-Benzoyl-1-methyl-3-pyrrolidinyl)-phenylmethanone

C19H19NO2 (293.1416)


   

1-[(4-Methylphenyl)methyl]-4-(1-pyrrolidinyl)pyrazolo[3,4-d]pyrimidine

1-[(4-Methylphenyl)methyl]-4-(1-pyrrolidinyl)pyrazolo[3,4-d]pyrimidine

C17H19N5 (293.164)


   

3,6-Diacetyl-9-propyl-9H-carbazole

3,6-Diacetyl-9-propyl-9H-carbazole

C19H19NO2 (293.1416)


   

3,6-Diacetyl-9-isopropylcarbazole

3,6-Diacetyl-9-isopropylcarbazole

C19H19NO2 (293.1416)


   

Quifenadine

Quifenadine

C20H23NO (293.178)


R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist

   

Amitriptylinoxide

Amitriptylinoxide

C20H23NO (293.178)


C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent

   

Butriptyline

Butriptyline

C21H27N (293.2143)


N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants > N06AA - Non-selective monoamine reuptake inhibitors D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent

   

Budipine

1-tert-butyl-4,4-diphenylpiperidine

C21H27N (293.2143)


D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents N - Nervous system > N04 - Anti-parkinson drugs > N04B - Dopaminergic agents C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent C93038 - Cation Channel Blocker Budipine is an anti-parkinson agent. Budipine also is a substrate of P-glycoprotein (P-gp), is mediated the uptake into the brain by P-gp. Budipine also is N-methyl-d-aspartate (NMDA) antagonist, and has indirect dopaminergic effects through an improved dopamine release, the inhibition of monoamine oxidase type B (MAO-B). Budipine can be used for the research of CNS disorders include Parkinson disease[1].

   

Embutramide

Embutramide

C17H27NO3 (293.1991)


C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent

   

3-Methyl-2-[[2,3,4-trihydroxy-5-(hydroxymethyl)oxolan-2-yl]methylamino]pentanoic acid

3-Methyl-2-[[2,3,4-trihydroxy-5-(hydroxymethyl)oxolan-2-yl]methylamino]pentanoic acid

C12H23NO7 (293.1474)


   

Levoprotiline

1-(methylamino)-3-{tetracyclo[6.6.2.0^{2,7}.0^{9,14}]hexadeca-2,4,6,9,11,13-hexaen-1-yl}propan-2-ol

C20H23NO (293.178)


C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent > C94727 - Tricyclic Antidepressant D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents

   

Colneleate

Colneleate

C18H29O3- (293.2117)


An oxo fatty acid anion and the conjugate base of colneleic acid, arising from deprotonation of the carboxylic acid group.

   

salinosporamide E

salinosporamide E

C16H23NO4 (293.1627)


   
   

8-[(1R,2R)-3-Oxo-2-{(Z)-pent-2-enyl}cyclopentyl]octanoate

8-[(1R,2R)-3-Oxo-2-{(Z)-pent-2-enyl}cyclopentyl]octanoate

C18H29O3- (293.2117)


   

9,10-epoxy-10,12Z-octadecadienoate

9,10-epoxy-10,12Z-octadecadienoate

C18H29O3- (293.2117)


   

(12Z,15Z)-9,10-epoxyoctadeca-12,15-dienoate

(12Z,15Z)-9,10-epoxyoctadeca-12,15-dienoate

C18H29O3- (293.2117)


   

(9Z,12Z)-15,16-epoxyoctadeca-9,12-dienoate

(9Z,12Z)-15,16-epoxyoctadeca-9,12-dienoate

C18H29O3- (293.2117)


   

(9Z,15Z)-12,13-epoxy-octadeca-9,15-dienoate

(9Z,15Z)-12,13-epoxy-octadeca-9,15-dienoate

C18H29O3- (293.2117)


   

9(S)-hydroxy-(10E,12Z,15Z)-octadeca-10,12,15-trienoate

9(S)-hydroxy-(10E,12Z,15Z)-octadeca-10,12,15-trienoate

C18H29O3- (293.2117)


   

(9Z,11E,13S,15Z)-13-hydroxyoctadeca-9,11,15-trienoate

(9Z,11E,13S,15Z)-13-hydroxyoctadeca-9,11,15-trienoate

C18H29O3- (293.2117)


   

(9Z,13S)-12,13-epoxyoctadeca-9,11-dienoate

(9Z,13S)-12,13-epoxyoctadeca-9,11-dienoate

C18H29O3- (293.2117)


A long-chain unsaturated fatty acid anion that is the conjugate base of (9Z,13S)-12,13-epoxyoctadeca-9,11-dienoic acid arising from deprotonation of the carboxylic acid function.

   

(11Z)-etheroleate

(11Z)-etheroleate

C18H29O3- (293.2117)


   

(omega5Z)-etheroleate

(omega5Z)-etheroleate

C18H29O3- (293.2117)


   

(9S,13S)-10-oxo-11-phytoenoate

(9S,13S)-10-oxo-11-phytoenoate

C18H29O3- (293.2117)


   

(9R,13R)-10-oxo-11-phytoenoate

(9R,13R)-10-oxo-11-phytoenoate

C18H29O3- (293.2117)


   
   

4-Coumaroyl-3-hydroxyagmatine

4-Coumaroyl-3-hydroxyagmatine

C14H21N4O3+ (293.1614)


   

3-(1-Adamantyl)-4-methyl-5-phenyl-1,2,4-triazole

3-(1-Adamantyl)-4-methyl-5-phenyl-1,2,4-triazole

C19H23N3 (293.1892)


   

(7Z)-12-[(dimethylamino)methyl]-4,8-dimethyl-3,14-dioxatricyclo[9.3.0.02,4]tetradec-7-en-13-one

(7Z)-12-[(dimethylamino)methyl]-4,8-dimethyl-3,14-dioxatricyclo[9.3.0.02,4]tetradec-7-en-13-one

C17H27NO3 (293.1991)


   

3,4,5-Trihydroxypentanoylcarnitine

3,4,5-Trihydroxypentanoylcarnitine

C12H23NO7 (293.1474)


   

3-oxo-2-(cis-2-pentenyl)-cyclopentane-1-octanoate

3-oxo-2-(cis-2-pentenyl)-cyclopentane-1-octanoate

C18H29O3- (293.2117)


   

(E,11E)-11-(3-pentyloxiran-2-ylidene)undec-9-enoate

(E,11E)-11-(3-pentyloxiran-2-ylidene)undec-9-enoate

C18H29O3- (293.2117)


   
   
   

7-Ethyl-2-methylundecan-4-yl sulfate

7-Ethyl-2-methylundecan-4-yl sulfate

C14H29O4S- (293.1786)


   

N-(4-cyclohexylphenyl)-2-(2-hydroxyethylthio)acetamide

N-(4-cyclohexylphenyl)-2-(2-hydroxyethylthio)acetamide

C16H23NO2S (293.1449)


   

2-[4-(tert-butyl)phenoxy]-N-{[(dimethylamino)carbonyl]oxy}ethanimidamide

2-[4-(tert-butyl)phenoxy]-N-{[(dimethylamino)carbonyl]oxy}ethanimidamide

C15H23N3O3 (293.1739)


   

3-(1-Benzylpiperidin-4-yl)triazolo[4,5-b]pyridine

3-(1-Benzylpiperidin-4-yl)triazolo[4,5-b]pyridine

C17H19N5 (293.164)


   

5-(Carbamoylamino)-2-[(2-phenylacetyl)amino]pentanoic acid

5-(Carbamoylamino)-2-[(2-phenylacetyl)amino]pentanoic acid

C14H19N3O4 (293.1375)


   

Phe-Ala-Gly

Phe-Ala-Gly

C14H19N3O4 (293.1375)


A tripeptide composed of L-phenylalanine, L-alanine, and glycine joined by peptide linkages.

   

3-cyclopentyl-N-(2-phenylphenyl)propanamide

3-cyclopentyl-N-(2-phenylphenyl)propanamide

C20H23NO (293.178)


   
   

3-cyclohexyl-N-(1,3-dimethyl-2,6-dioxo-4-pyrimidinyl)propanamide

3-cyclohexyl-N-(1,3-dimethyl-2,6-dioxo-4-pyrimidinyl)propanamide

C15H23N3O3 (293.1739)


   

1-(4-Butylphenyl)-3-(4-morpholinyl)thiourea

1-(4-Butylphenyl)-3-(4-morpholinyl)thiourea

C15H23N3OS (293.1562)


   

(R)-2-hydroxy-alpha-linolenate

(R)-2-hydroxy-alpha-linolenate

C18H29O3- (293.2117)


A hydroxy fatty acid anion that is the conjugate base of (R)-2-hydroxy-alpha-linolenic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

2-(2,3-dihydro-1H-inden-5-yloxy)-1-(2,3-dihydroindol-1-yl)ethanone

2-(2,3-dihydro-1H-inden-5-yloxy)-1-(2,3-dihydroindol-1-yl)ethanone

C19H19NO2 (293.1416)


   

(Z,E)-13-oxooctadeca-9,11-dienoate

(Z,E)-13-oxooctadeca-9,11-dienoate

C18H29O3- (293.2117)


   

3-(1H-indazol-6-yl)-1-propan-2-yl-4-pyrazolo[3,4-d]pyrimidinamine

3-(1H-indazol-6-yl)-1-propan-2-yl-4-pyrazolo[3,4-d]pyrimidinamine

C15H15N7 (293.1389)


   

Fructosyl leucine

Fructosyl leucine

C12H23NO7 (293.1474)


   

Sieboldine A(rel)

Sieboldine A(rel)

C16H23NO4 (293.1627)


A natural product found in Lycopodium sieboldii.

   

Fructosyl isoleucine

Fructosyl isoleucine

C12H23NO7 (293.1474)


   

9-Ethyl-6-[2-(3-pyridinyl)ethylamino]-2-purinecarbonitrile

9-Ethyl-6-[2-(3-pyridinyl)ethylamino]-2-purinecarbonitrile

C15H15N7 (293.1389)


   

8-{(2S)-3-[(2Z)-oct-2-en-1-ylidene]oxiran-2-yl}octanoate

8-{(2S)-3-[(2Z)-oct-2-en-1-ylidene]oxiran-2-yl}octanoate

C18H29O3- (293.2117)


   

N(alpha)-acetyl-L-histidyl-D-prolinamide

N(alpha)-acetyl-L-histidyl-D-prolinamide

C13H19N5O3 (293.1488)


   

1-(2,6-Dimethyl-4-morpholinyl)-3-(3,5-dimethylphenoxy)-2-propanol

1-(2,6-Dimethyl-4-morpholinyl)-3-(3,5-dimethylphenoxy)-2-propanol

C17H27NO3 (293.1991)


   

N-[(2R,3R,6R)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-2-pyridin-4-ylacetamide

N-[(2R,3R,6R)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-2-pyridin-4-ylacetamide

C15H23N3O3 (293.1739)


   

N-[(2R,3R,6S)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-2-pyridin-4-ylacetamide

N-[(2R,3R,6S)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-2-pyridin-4-ylacetamide

C15H23N3O3 (293.1739)


   

N-[(2S,3R,6S)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-2-pyridin-4-ylacetamide

N-[(2S,3R,6S)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-2-pyridin-4-ylacetamide

C15H23N3O3 (293.1739)


   

N-[(2R,3S,6R)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-2-pyridin-4-ylacetamide

N-[(2R,3S,6R)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-2-pyridin-4-ylacetamide

C15H23N3O3 (293.1739)


   

N-[(2S,3R,6R)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-2-pyridin-4-ylacetamide

N-[(2S,3R,6R)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-2-pyridin-4-ylacetamide

C15H23N3O3 (293.1739)


   

N-[(2S,3S,6R)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-2-pyridin-4-ylacetamide

N-[(2S,3S,6R)-6-(2-aminoethyl)-2-(hydroxymethyl)-3-oxanyl]-2-pyridin-4-ylacetamide

C15H23N3O3 (293.1739)


   

2-[(3E)-3-ethylidene-1,2,4,12-tetrahydroindolo[2,3-a]quinolizin-5-ium-2-yl]ethanol

2-[(3E)-3-ethylidene-1,2,4,12-tetrahydroindolo[2,3-a]quinolizin-5-ium-2-yl]ethanol

C19H21N2O+ (293.1654)


   
   
   
   

9-HOTrE(1-)

9-HOTrE(1-)

C18H29O3- (293.2117)


A polyunsaturated fatty acid anion that is the conjugate base of 9-HOTrE, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

N(2)-[(R)-2-amino-2-phenylacetyl]-N-butyl-L-serinamide

N(2)-[(R)-2-amino-2-phenylacetyl]-N-butyl-L-serinamide

C15H23N3O3 (293.1739)


   

8-[(1R,2R)-3-oxo-2-{(Z)-pent-2-en-1-yl}cyclopentyl]octanoate

8-[(1R,2R)-3-oxo-2-{(Z)-pent-2-en-1-yl}cyclopentyl]octanoate

C18H29O3- (293.2117)


   

N(2)-[(R)-2-amino-2-(4-hydroxyphenyl)acetyl]-N-butyl-L-alaninamide

N(2)-[(R)-2-amino-2-(4-hydroxyphenyl)acetyl]-N-butyl-L-alaninamide

C15H23N3O3 (293.1739)


   

methyl 4,6-dideoxy-4-[(2S)-2,4-dihydroxybutanamido]-2-O-methyl-alpha-D-mannopyranoside

methyl 4,6-dideoxy-4-[(2S)-2,4-dihydroxybutanamido]-2-O-methyl-alpha-D-mannopyranoside

C12H23NO7 (293.1474)


   

(10E,12Z)-9-Oxooctadeca-10,12-dienoate

(10E,12Z)-9-Oxooctadeca-10,12-dienoate

C18H29O3- (293.2117)


   

5-oxo-(6E,8Z)-octadecadienoate

5-oxo-(6E,8Z)-octadecadienoate

C18H29O3- (293.2117)


   

alpha-mycolate type-3 (V)

alpha-mycolate type-3 (V)

C18H29O3- (293.2117)


   

(10S)-hydroxy-(6Z,12Z,15Z)-octadecatrienoate

(10S)-hydroxy-(6Z,12Z,15Z)-octadecatrienoate

C18H29O3- (293.2117)


   

trimethyl-[(1R,9S)-1-methyl-16-azatetracyclo[7.6.1.02,7.010,15]hexadeca-2,4,6,10(15),11,13-hexaen-13-yl]silane

trimethyl-[(1R,9S)-1-methyl-16-azatetracyclo[7.6.1.02,7.010,15]hexadeca-2,4,6,10(15),11,13-hexaen-13-yl]silane

C19H23NSi (293.16)


   

trimethyl-[(1S,9R)-1-methyl-16-azatetracyclo[7.6.1.02,7.010,15]hexadeca-2,4,6,10(15),11,13-hexaen-13-yl]silane

trimethyl-[(1S,9R)-1-methyl-16-azatetracyclo[7.6.1.02,7.010,15]hexadeca-2,4,6,10(15),11,13-hexaen-13-yl]silane

C19H23NSi (293.16)


   

N-(3,3-Diphenylpropionyl)pyrrolidin-2-one

N-(3,3-Diphenylpropionyl)pyrrolidin-2-one

C19H19NO2 (293.1416)


   

N-Methyl-N-bis(trimethylsilyl)methylbenzamide

N-Methyl-N-bis(trimethylsilyl)methylbenzamide

C15H27NOSi2 (293.1631)


   

2-Butoxy-N-(2-(diethylamino)ethyl)-3-pyridinecarboxamide

2-Butoxy-N-(2-(diethylamino)ethyl)-3-pyridinecarboxamide

C16H27N3O2 (293.2103)


   

2,2-Dimethyl-3-[[[(1-phenylethyl)amino]carbonyl]oxy]propionic acid ethyl ester

2,2-Dimethyl-3-[[[(1-phenylethyl)amino]carbonyl]oxy]propionic acid ethyl ester

C16H23NO4 (293.1627)


   
   

Phenylalanyllysine

Phenylalanyllysine

C15H23N3O3 (293.1739)


   

Glutaminylphenylalanine

Glutaminylphenylalanine

C14H19N3O4 (293.1375)


   

N-Acetyl-3-hydroxyprocainamide

N-Acetyl-3-hydroxyprocainamide

C15H23N3O3 (293.1739)


   

Phenylalanyl-Gamma-glutamate

Phenylalanyl-Gamma-glutamate

C14H19N3O4 (293.1375)


   

N-(1-Deoxy-1-fructosyl)leucine

N-(1-Deoxy-1-fructosyl)leucine

C12H23NO7 (293.1474)


   

N-(1-Deoxy-1-fructosyl)isoleucine

N-(1-Deoxy-1-fructosyl)isoleucine

C12H23NO7 (293.1474)


   

Phenanthro(3,4-d)-1,3-dioxole-5-ethanamine, N,N-dimethyl-

Phenanthro(3,4-d)-1,3-dioxole-5-ethanamine, N,N-dimethyl-

C19H19NO2 (293.1416)


   

Phenylalanyl-Lysine

Phenylalanyl-Lysine

C15H23N3O3 (293.1739)


   

tetradecyl sulfate

tetradecyl sulfate

C14H29O4S (293.1786)


An organosulfate oxoanion that is the conjugate base of tetradecyl sulfonic acid, obtained by deprotonation of the O-sulfo group.

   

glutaminyl-phenylalanine

glutaminyl-phenylalanine

C14H19N3O4 (293.1375)


   

9-oxo-ODE(1-)

9-oxo-ODE(1-)

C18H29O3 (293.2117)


A octadecanoid anion that is the conjugate base of 9-oxo-ODE, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

13(S)-HOTrE(1-)

13(S)-HOTrE(1-)

C18H29O3 (293.2117)


A polyunsaturated fatty acid anion that is the conjugate base of 13S-HOTrE arising from deprotonation of the carboxylic acid function; major species at pH 7.3.

   

13-oxo-9Z,11E-ODE(1-)

13-oxo-9Z,11E-ODE(1-)

C18H29O3 (293.2117)


A polyunsaturated fatty acid anion that is the conjugate base of 13-oxo-9Z,11E-ODE, arising from deprotonation of the carboxylic acid function; major species at pH 7.3.

   

(8R)-7-prop-2-enyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-13,14-diol

(8R)-7-prop-2-enyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-13,14-diol

C19H19NO2 (293.1416)


   

8-[(1S,2S)-3-oxo-2-{(Z)-pent-2-en-1-yl}cyclopentyl]octanoate

8-[(1S,2S)-3-oxo-2-{(Z)-pent-2-en-1-yl}cyclopentyl]octanoate

C18H29O3 (293.2117)


An oxo monocarboxylic acid anion that is the conjugate base of 8-[(1S,2S)-3-oxo-2-{(Z)-pent-2-en-1-yl}cyclopentyl]octanoic acid resulting from the deprotonation of the carboxy group; major species at pH 7.3.

   

NA-Dopamine 9:0

NA-Dopamine 9:0

C17H27NO3 (293.1991)


   

NA-Taurine 11:0

NA-Taurine 11:0

C13H27NO4S (293.1661)


   
   

Cyclo(Arg-His)

Cyclo(Arg-His)

C12H19N7O2 (293.16)


   
   
   

(+)-N-Allylnormetazocine (hydrochloride)

(+)-N-Allylnormetazocine (hydrochloride)

C17H24ClNO (293.1546)


(+)-N-Allylnormetazocine ((+)-SKF 10047) hydrochloride is a benzomorphan opioid with psychotomi metic effects. (+)-N-Allylnormetazocine hydrochloride is an opioid receptor antagonist with Ki values of 300 nM and 27 μM for σ1 and σ2 opioid receptors, respectively. (+)-N-Allylnormetazocine hydrochloride can be used for the research of neurological disease[1][2].

   

(1r,2s,5s,6r,8r,11s)-5-[(dimethylamino)methyl]-11-isopropyl-6-methyl-9-oxatricyclo[6.2.1.0²,⁶]undecane-7,10-dione

(1r,2s,5s,6r,8r,11s)-5-[(dimethylamino)methyl]-11-isopropyl-6-methyl-9-oxatricyclo[6.2.1.0²,⁶]undecane-7,10-dione

C17H27NO3 (293.1991)


   

n-[(4-hydroxy-3-methoxyphenyl)methyl]-7-methyloctanimidic acid

n-[(4-hydroxy-3-methoxyphenyl)methyl]-7-methyloctanimidic acid

C17H27NO3 (293.1991)


   

3,4,6-trimethyl-9-phenyl-7-oxa-11-azatricyclo[6.4.0.0²,⁶]dodeca-1(12),4,8,10-tetraen-12-ol

3,4,6-trimethyl-9-phenyl-7-oxa-11-azatricyclo[6.4.0.0²,⁶]dodeca-1(12),4,8,10-tetraen-12-ol

C19H19NO2 (293.1416)


   

9-methoxy-3,3,10-trimethyl-7h-pyrano[2,3-c]carbazole

9-methoxy-3,3,10-trimethyl-7h-pyrano[2,3-c]carbazole

C19H19NO2 (293.1416)


   

5-[(dimethylamino)methyl]-11-isopropyl-6-methyl-9-oxatricyclo[6.2.1.0²,⁶]undecane-7,10-dione

5-[(dimethylamino)methyl]-11-isopropyl-6-methyl-9-oxatricyclo[6.2.1.0²,⁶]undecane-7,10-dione

C17H27NO3 (293.1991)


   

3-hydroxy-2-oxodendrobine

NA

C16H23NO4 (293.1627)


{"Ingredient_id": "HBIN008646","Ingredient_name": "3-hydroxy-2-oxodendrobine","Alias": "NA","Ingredient_formula": "C16H23NO4","Ingredient_Smile": "NA","Ingredient_weight": "293.36","OB_score": "NA","CAS_id": "99616-00-9","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8095","PubChem_id": "NA","DrugBank_id": "NA"}

   

9-methoxy-3,3,8-trimethyl-11h-pyrano[3,2-a]carbazole

9-methoxy-3,3,8-trimethyl-11h-pyrano[3,2-a]carbazole

C19H19NO2 (293.1416)


   

(1r,4r,5s)-1-[(s)-(1s)-cyclohex-2-en-1-yl(hydroxy)methyl]-3-hydroxy-5-methyl-4-propyl-6-oxa-2-azabicyclo[3.2.0]hept-2-en-7-one

(1r,4r,5s)-1-[(s)-(1s)-cyclohex-2-en-1-yl(hydroxy)methyl]-3-hydroxy-5-methyl-4-propyl-6-oxa-2-azabicyclo[3.2.0]hept-2-en-7-one

C16H23NO4 (293.1627)


   

(2s)-2-[(2e)-but-2-en-2-yl]-3-methyl-8-phenyl-2h-pyrano[3,2-c]pyridin-5-ol

(2s)-2-[(2e)-but-2-en-2-yl]-3-methyl-8-phenyl-2h-pyrano[3,2-c]pyridin-5-ol

C19H19NO2 (293.1416)


   

(5z)-1-acetyl-5-ethylidene-4-hydroxy-3-octanoylpyrrol-2-one

(5z)-1-acetyl-5-ethylidene-4-hydroxy-3-octanoylpyrrol-2-one

C16H23NO4 (293.1627)


   

10-methoxy-3,3,5-trimethyl-11h-pyrano[3,2-a]carbazole

10-methoxy-3,3,5-trimethyl-11h-pyrano[3,2-a]carbazole

C19H19NO2 (293.1416)


   

2,3-dihydroxy-14-methyl-11-oxa-5-azapentacyclo[7.4.3.1¹⁰,¹³.0¹,¹⁶.0⁵,¹⁶]heptadecan-12-one

2,3-dihydroxy-14-methyl-11-oxa-5-azapentacyclo[7.4.3.1¹⁰,¹³.0¹,¹⁶.0⁵,¹⁶]heptadecan-12-one

C16H23NO4 (293.1627)


   

3,5,8-trimethyl-9-oxa-7-azatetracyclo[8.8.0.0²,⁸.0¹²,¹⁷]octadeca-1(18),4,6,10,12,14,16-heptaen-6-ol

3,5,8-trimethyl-9-oxa-7-azatetracyclo[8.8.0.0²,⁸.0¹²,¹⁷]octadeca-1(18),4,6,10,12,14,16-heptaen-6-ol

C19H19NO2 (293.1416)


   

1-methoxy-2-(3-methylbut-2-en-1-yl)-9h-carbazole-3-carbaldehyde

1-methoxy-2-(3-methylbut-2-en-1-yl)-9h-carbazole-3-carbaldehyde

C19H19NO2 (293.1416)


   

(2r)-2-[(2e)-but-2-en-2-yl]-3-methyl-8-phenyl-2h-pyrano[3,2-c]pyridin-5-ol

(2r)-2-[(2e)-but-2-en-2-yl]-3-methyl-8-phenyl-2h-pyrano[3,2-c]pyridin-5-ol

C19H19NO2 (293.1416)


   

(2r,3s,6r)-3,4,6-trimethyl-9-phenyl-7-oxa-11-azatricyclo[6.4.0.0²,⁶]dodeca-1(12),4,8,10-tetraen-12-ol

(2r,3s,6r)-3,4,6-trimethyl-9-phenyl-7-oxa-11-azatricyclo[6.4.0.0²,⁶]dodeca-1(12),4,8,10-tetraen-12-ol

C19H19NO2 (293.1416)


   

(7as)-2-decanoyl-1-hydroxy-5,6,7,7a-tetrahydropyrrolizin-3-one

(7as)-2-decanoyl-1-hydroxy-5,6,7,7a-tetrahydropyrrolizin-3-one

C17H27NO3 (293.1991)


   

dimethyl(2-{2h-phenanthro[3,4-d][1,3]dioxol-5-yl}ethyl)amine

dimethyl(2-{2h-phenanthro[3,4-d][1,3]dioxol-5-yl}ethyl)amine

C19H19NO2 (293.1416)


   

(5e,8r,9e)-3-(c-hydroxycarbonimidoylmethyl)-8,10-dimethyl-7-oxododeca-5,9,11-trienoic acid

(5e,8r,9e)-3-(c-hydroxycarbonimidoylmethyl)-8,10-dimethyl-7-oxododeca-5,9,11-trienoic acid

C16H23NO4 (293.1627)


   

13-hydroxy-6-methyl-17-oxa-13-azatetracyclo[12.2.1.0¹,⁹.0⁴,⁹]heptadecane-2,8-dione

13-hydroxy-6-methyl-17-oxa-13-azatetracyclo[12.2.1.0¹,⁹.0⁴,⁹]heptadecane-2,8-dione

C16H23NO4 (293.1627)


   

8-methoxy-3,3,5-trimethyl-11h-pyrano[3,2-a]carbazole

8-methoxy-3,3,5-trimethyl-11h-pyrano[3,2-a]carbazole

C19H19NO2 (293.1416)


   

(2r,3r,8r)-3,5,8-trimethyl-9-oxa-7-azatetracyclo[8.8.0.0²,⁸.0¹²,¹⁷]octadeca-1(18),4,6,10,12,14,16-heptaen-6-ol

(2r,3r,8r)-3,5,8-trimethyl-9-oxa-7-azatetracyclo[8.8.0.0²,⁸.0¹²,¹⁷]octadeca-1(18),4,6,10,12,14,16-heptaen-6-ol

C19H19NO2 (293.1416)


   

(2e,7e,9e)-n-(2-hydroxy-2-methylpropyl)-6,11-dioxododeca-2,7,9-trienimidic acid

(2e,7e,9e)-n-(2-hydroxy-2-methylpropyl)-6,11-dioxododeca-2,7,9-trienimidic acid

C16H23NO4 (293.1627)


   

(2r,3s,6r)-3,4,6-trimethyl-11-phenyl-7-oxa-9-azatricyclo[6.4.0.0²,⁶]dodeca-1(12),4,8,10-tetraen-12-ol

(2r,3s,6r)-3,4,6-trimethyl-11-phenyl-7-oxa-9-azatricyclo[6.4.0.0²,⁶]dodeca-1(12),4,8,10-tetraen-12-ol

C19H19NO2 (293.1416)


   

6-hydroxy-4-[(2r,5s,6e)-2-hydroxy-5,7-dimethyl-4-oxonona-6,8-dien-1-yl]-4,5-dihydro-3h-pyridin-2-one

6-hydroxy-4-[(2r,5s,6e)-2-hydroxy-5,7-dimethyl-4-oxonona-6,8-dien-1-yl]-4,5-dihydro-3h-pyridin-2-one

C16H23NO4 (293.1627)


   

(2s)-6-amino-2-{[(2s)-2-amino-1-hydroxy-3-phenylpropylidene]amino}hexanoic acid

(2s)-6-amino-2-{[(2s)-2-amino-1-hydroxy-3-phenylpropylidene]amino}hexanoic acid

C15H23N3O3 (293.1739)


   

methyl 2-[(2s)-1-{4-[(2e)-4-methyl-5-oxofuran-2-ylidene]butyl}pyrrolidin-2-yl]acetate

methyl 2-[(2s)-1-{4-[(2e)-4-methyl-5-oxofuran-2-ylidene]butyl}pyrrolidin-2-yl]acetate

C16H23NO4 (293.1627)


   

(1s,2s,5s,6r,8s,11s)-5-[(dimethylamino)methyl]-11-isopropyl-6-methyl-9-oxatricyclo[6.2.1.0²,⁶]undecane-7,10-dione

(1s,2s,5s,6r,8s,11s)-5-[(dimethylamino)methyl]-11-isopropyl-6-methyl-9-oxatricyclo[6.2.1.0²,⁶]undecane-7,10-dione

C17H27NO3 (293.1991)


   

(2e)-5-[(6s)-5-(hydroxymethyl)-6-methyl-4-oxatricyclo[3.3.1.0²,⁷]nonan-2-yl]-2-methyl-4-oxopent-2-enimidic acid

(2e)-5-[(6s)-5-(hydroxymethyl)-6-methyl-4-oxatricyclo[3.3.1.0²,⁷]nonan-2-yl]-2-methyl-4-oxopent-2-enimidic acid

C16H23NO4 (293.1627)


   

n-(2-methylpropyl)-3-(3,4,5-trimethoxyphenyl)prop-2-enimidic acid

n-(2-methylpropyl)-3-(3,4,5-trimethoxyphenyl)prop-2-enimidic acid

C16H23NO4 (293.1627)


   

3-isopropyl-9,9-dimethyl-15-azatetracyclo[10.2.1.0⁵,¹⁴.0⁸,¹³]pentadeca-1(14),3,5,7,12-pentaene-2,11-dione

3-isopropyl-9,9-dimethyl-15-azatetracyclo[10.2.1.0⁵,¹⁴.0⁸,¹³]pentadeca-1(14),3,5,7,12-pentaene-2,11-dione

C19H19NO2 (293.1416)


   

methyl 2-{1-[4-(4-methyl-5-oxofuran-2-ylidene)butyl]pyrrolidin-2-yl}acetate

methyl 2-{1-[4-(4-methyl-5-oxofuran-2-ylidene)butyl]pyrrolidin-2-yl}acetate

C16H23NO4 (293.1627)


   

(9r,9as)-9-[(1s)-1-[(2s,4r)-4-methyl-5-oxooxolan-2-yl]propyl]-octahydropyrrolo[1,2-a]azepin-3-one

(9r,9as)-9-[(1s)-1-[(2s,4r)-4-methyl-5-oxooxolan-2-yl]propyl]-octahydropyrrolo[1,2-a]azepin-3-one

C17H27NO3 (293.1991)


   

n-[(4-hydroxy-3-methoxyphenyl)methyl]nonanimidic acid

n-[(4-hydroxy-3-methoxyphenyl)methyl]nonanimidic acid

C17H27NO3 (293.1991)


   

(2r,3r,8s)-3,5,8-trimethyl-9-oxa-7-azatetracyclo[8.8.0.0²,⁸.0¹²,¹⁷]octadeca-1(18),4,6,10,12,14,16-heptaen-6-ol

(2r,3r,8s)-3,5,8-trimethyl-9-oxa-7-azatetracyclo[8.8.0.0²,⁸.0¹²,¹⁷]octadeca-1(18),4,6,10,12,14,16-heptaen-6-ol

C19H19NO2 (293.1416)


   

11-methoxy-2-methyl-1h,3h,4h-naphtho[2,1-f]isoquinolin-12-ol

11-methoxy-2-methyl-1h,3h,4h-naphtho[2,1-f]isoquinolin-12-ol

C19H19NO2 (293.1416)


   

2-[2-(3,4-dimethoxyphenyl)ethyl]quinoline

2-[2-(3,4-dimethoxyphenyl)ethyl]quinoline

C19H19NO2 (293.1416)


   

1-methoxy-4-(3-methylbut-2-en-1-yl)-9h-carbazole-3-carbaldehyde

1-methoxy-4-(3-methylbut-2-en-1-yl)-9h-carbazole-3-carbaldehyde

C19H19NO2 (293.1416)


   

(2s,3r,8r)-3,5,8-trimethyl-9-oxa-7-azatetracyclo[8.8.0.0²,⁸.0¹²,¹⁷]octadeca-1(18),4,6,10,12,14,16-heptaen-6-ol

(2s,3r,8r)-3,5,8-trimethyl-9-oxa-7-azatetracyclo[8.8.0.0²,⁸.0¹²,¹⁷]octadeca-1(18),4,6,10,12,14,16-heptaen-6-ol

C19H19NO2 (293.1416)


   

(1r,2s,3s,9s,10r,13s,14r,16s)-2,3-dihydroxy-14-methyl-11-oxa-5-azapentacyclo[7.4.3.1¹⁰,¹³.0¹,¹⁶.0⁵,¹⁶]heptadecan-12-one

(1r,2s,3s,9s,10r,13s,14r,16s)-2,3-dihydroxy-14-methyl-11-oxa-5-azapentacyclo[7.4.3.1¹⁰,¹³.0¹,¹⁶.0⁵,¹⁶]heptadecan-12-one

C16H23NO4 (293.1627)


   

(1r,4s,6r,9s,14s)-13-hydroxy-6-methyl-17-oxa-13-azatetracyclo[12.2.1.0¹,⁹.0⁴,⁹]heptadecane-2,8-dione

(1r,4s,6r,9s,14s)-13-hydroxy-6-methyl-17-oxa-13-azatetracyclo[12.2.1.0¹,⁹.0⁴,⁹]heptadecane-2,8-dione

C16H23NO4 (293.1627)


   

(2s,3r,6s)-3,4,6-trimethyl-11-phenyl-7-oxa-9-azatricyclo[6.4.0.0²,⁶]dodeca-1(12),4,8,10-tetraen-12-ol

(2s,3r,6s)-3,4,6-trimethyl-11-phenyl-7-oxa-9-azatricyclo[6.4.0.0²,⁶]dodeca-1(12),4,8,10-tetraen-12-ol

C19H19NO2 (293.1416)


   

1-[cyclohex-2-en-1-yl(hydroxy)methyl]-3-hydroxy-5-methyl-4-propyl-6-oxa-2-azabicyclo[3.2.0]hept-2-en-7-one

1-[cyclohex-2-en-1-yl(hydroxy)methyl]-3-hydroxy-5-methyl-4-propyl-6-oxa-2-azabicyclo[3.2.0]hept-2-en-7-one

C16H23NO4 (293.1627)


   

15,16-dimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,13,15-heptaene

15,16-dimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,13,15-heptaene

C19H19NO2 (293.1416)


   

6-amino-2-[(2-amino-1-hydroxy-3-phenylpropylidene)amino]hexanoic acid

6-amino-2-[(2-amino-1-hydroxy-3-phenylpropylidene)amino]hexanoic acid

C15H23N3O3 (293.1739)


   

8-methoxy-3,3,9-trimethyl-11h-pyrano[3,2-a]carbazole

8-methoxy-3,3,9-trimethyl-11h-pyrano[3,2-a]carbazole

C19H19NO2 (293.1416)


   

6-hydroxy-4-(2-hydroxy-5,7-dimethyl-4-oxonona-6,8-dien-1-yl)-4,5-dihydro-3h-pyridin-2-one

6-hydroxy-4-(2-hydroxy-5,7-dimethyl-4-oxonona-6,8-dien-1-yl)-4,5-dihydro-3h-pyridin-2-one

C16H23NO4 (293.1627)


   

9-methoxy-2,2,8-trimethyl-11h-pyrano[2,3-a]carbazole

9-methoxy-2,2,8-trimethyl-11h-pyrano[2,3-a]carbazole

C19H19NO2 (293.1416)


   

9-methoxy-3,3,5-trimethyl-11h-pyrano[3,2-a]carbazole

9-methoxy-3,3,5-trimethyl-11h-pyrano[3,2-a]carbazole

C19H19NO2 (293.1416)


   

8-methylnonyl 2-amino-5-hydroxybenzoate

8-methylnonyl 2-amino-5-hydroxybenzoate

C17H27NO3 (293.1991)


   

5-[5-(hydroxymethyl)-6-methyl-4-oxatricyclo[3.3.1.0²,⁷]nonan-2-yl]-2-methyl-4-oxopent-2-enimidic acid

5-[5-(hydroxymethyl)-6-methyl-4-oxatricyclo[3.3.1.0²,⁷]nonan-2-yl]-2-methyl-4-oxopent-2-enimidic acid

C16H23NO4 (293.1627)


   

({4-methoxy-1h,1'h-[2,2'-bipyrrol]-5-yl}methylidene)(2-phenylethyl)amine

({4-methoxy-1h,1'h-[2,2'-bipyrrol]-5-yl}methylidene)(2-phenylethyl)amine

C18H19N3O (293.1528)


   

(2e)-n-(2-methylpropyl)-3-(3,4,5-trimethoxyphenyl)prop-2-enimidic acid

(2e)-n-(2-methylpropyl)-3-(3,4,5-trimethoxyphenyl)prop-2-enimidic acid

C16H23NO4 (293.1627)


   

1-acetyl-5-ethylidene-4-hydroxy-3-octanoylpyrrol-2-one

1-acetyl-5-ethylidene-4-hydroxy-3-octanoylpyrrol-2-one

C16H23NO4 (293.1627)


   

9-[1-(4-methyl-5-oxooxolan-2-yl)propyl]-octahydropyrrolo[1,2-a]azepin-3-one

9-[1-(4-methyl-5-oxooxolan-2-yl)propyl]-octahydropyrrolo[1,2-a]azepin-3-one

C17H27NO3 (293.1991)